Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Novo Nordisk is a global healthcare company with nearly 100 years of innovation and leadership in diabetes care. Building on this heritage, Novo Nordisk is also driving change to defeat obesity, rare blood disorders, and rare endocrine disorders. Headquartered in Denmark, Novo Nordisk employs approximately 64,300 people in 80 offices and markets its products in around 170 countries. Their purpose is to drive change to defeat serious chronic diseases, built upon their heritage in diabetes.
Serves as the central hub for global operations, research and development leadership, corporate strategy, and administrative functions.
The campus, partly designed by Henning Larsen Architects, features modern, interconnected buildings, advanced research labs, and extensive green spaces. It emphasizes Scandinavian design principles, sustainability (e.g., low-energy consumption buildings), and employee well-being with amenities like fitness centers and canteens.
Characterized by a strong emphasis on scientific innovation, patient-centricity, collaboration, and a commitment to sustainability and social responsibility. It fosters a diverse and inclusive environment with a focus on work-life balance and continuous learning.
The Bagsværd headquarters is pivotal as the birthplace of many of Novo Nordisk's groundbreaking treatments and represents the company's long-standing commitment to Denmark and its leadership in the global pharmaceutical industry.
Novo Nordisk operates globally, supporting functions such as research and development, manufacturing, commercial operations, clinical trials, regulatory affairs, and patient support programs. The company has offices in 80 countries and its products are marketed in approximately 170 countries worldwide, reflecting its extensive reach in addressing chronic diseases.
Novo Allé 1
Bagsværd
Capital Region of Denmark
Denmark
Address: 800 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA
Drives Novo Nordisk's strategy and presence in the United States, focusing on delivering innovative medicines to patients and engaging with healthcare stakeholders in this major market.
Address: 530 Fairview Ave N, Seattle, WA 98109, USA
Leverages the vibrant biotech ecosystem in Seattle to advance scientific discovery and innovation for new therapeutic targets and drug candidates.
Address: Novo Nordisk Research & Development Center, No. 20 Life Science Park Road, Changping District, Beijing, China
Strengthens Novo Nordisk's R&D capabilities in Asia and addresses specific healthcare challenges in China, a rapidly growing market for the company.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Novo Nordisk' leadership includes:
Novo Nordisk has been backed by several prominent investors over the years, including:
In the past year, Novo Nordisk announced a key leadership transition within its International Operations, promoting Natalia Miao to Executive Vice President, succeeding Maziar Mike Doustdar who moved to an advisory role before his planned retirement.
Discover the tools Novo Nordisk uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Novo Nordisk primarily utilizes a few common email formats for its employees globally. The most prevalent patterns include using the employee's first initial followed by their last name, or their full first name separated by a period from their last name, followed by '@novonordisk.com'.
Common formats include [first_initial][last_name]@novonordisk.com (e.g., jdoe@novonordisk.com) and [first_name].[last_name]@novonordisk.com (e.g., jane.doe@novonordisk.com).
Format
jdoe@novonordisk.com
Example
85%
Success rate
Novo Nordisk Press Release • May 24, 2024
Novo Nordisk announced a USD 4.1 billion (DKK 28 billion) investment to build a second fill and finishing manufacturing facility in Clayton, North Carolina, US. This expansion aims to increase manufacturing capacity for current and future injectable treatments for diabetes and obesity, including its GLP-1 products....more
Novo Nordisk Press Release • May 2, 2024
In the first three months of 2024, Novo Nordisk's sales increased by 22% in Danish kroner and by 24% at constant exchange rates (CER) to DKK 65.3 billion. Sales growth was driven by both Diabetes and Obesity care, with North America Operations and International Operations contributing significantly....more
Fierce Pharma • April 11, 2024
Novo Nordisk entered into a collaboration and license agreement with German biotech Cardior Pharmaceuticals to develop and commercialize Cardior’s lead compound CDR132L, targeting heart failure. The deal includes an upfront payment and potential milestone payments exceeding $1 billion....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Novo Nordisk, are just a search away.